相似文献
1
Cell-permeable esters of diazeniumdiolate-based nitric oxide prodrugs.
Org Lett. 2008 Nov 20;10(22):5155-8. doi: 10.1021/ol8020989. Epub 2008 Oct 29.
2
Hybrid molecule from O2-(2,4-dinitrophenyl)diazeniumdiolate and oleanolic acid: a glutathione S-transferase π-activated nitric oxide prodrug with selective anti-human hepatocellular carcinoma activity and improved stability.
J Med Chem. 2013 Jun 13;56(11):4641-55. doi: 10.1021/jm400393u. Epub 2013 May 16.
3
Synthesis, mechanistic studies, and anti-proliferative activity of glutathione/glutathione S-transferase-activated nitric oxide prodrugs.
Bioorg Med Chem. 2008 Nov 15;16(22):9764-71. doi: 10.1016/j.bmc.2008.09.063. Epub 2008 Sep 30.
4
Nitric oxide prodrugs: diazeniumdiolate anions of hindered secondary amines.
Org Lett. 2007 Oct 25;9(22):4551-4. doi: 10.1021/ol7019636. Epub 2007 Oct 5.
5
Nitroreductase-activated nitric oxide (NO) prodrugs.
Bioorg Med Chem Lett. 2013 Nov 1;23(21):5964-7. doi: 10.1016/j.bmcl.2013.08.066. Epub 2013 Aug 22.
6
Diazeniumdiolated carbamates: a novel class of nitric oxide donors.
Bioorg Med Chem. 2012 Mar 15;20(6):2025-9. doi: 10.1016/j.bmc.2012.01.046. Epub 2012 Feb 4.
7
Cellular resistance to a nitric oxide releasing glutathione S-transferase P-activated prodrug, PABA/NO.
Invest New Drugs. 2011 Oct;29(5):719-29. doi: 10.1007/s10637-010-9407-5. Epub 2010 Mar 16.
8
JS-K, a glutathione/glutathione S-transferase-activated nitric oxide donor of the diazeniumdiolate class with potent antineoplastic activity.
Mol Cancer Ther. 2003 Apr;2(4):409-17.
9
Synthesis, nitric oxide release, and anti-leukemic activity of glutathione-activated nitric oxide prodrugs: Structural analogues of PABA/NO, an anti-cancer lead compound.
Bioorg Med Chem. 2008 Mar 1;16(5):2657-64. doi: 10.1016/j.bmc.2007.11.035. Epub 2007 Nov 17.
10
Nitric oxide-releasing prodrug triggers cancer cell death through deregulation of cellular redox balance.
Redox Biol. 2013 Feb 1;1(1):115-24. doi: 10.1016/j.redox.2012.12.002. eCollection 2013.
引用本文的文献
1
The Nitric Oxide Prodrug V-PROLI/NO Inhibits Cellular Uptake of Proline.
ACS Med Chem Lett. 2010 Nov 11;1(8):386-389. doi: 10.1021/ml1000905.
2
Glycosylated PROLI/NO derivatives as nitric oxide prodrugs.
Org Lett. 2010 Jan 1;12(1):56-9. doi: 10.1021/ol902481s.
3
Mechanistic studies on the reaction between R2N-NONOates and aquacobalamin: evidence for direct transfer of a nitroxyl group from R2N-NONOates to cobalt(III) centers.
Angew Chem Int Ed Engl. 2009;48(47):8909-13. doi: 10.1002/anie.200904360.
4
Synthesis and evaluation of piperazine and homopiperazine analogues of JS-K, an anti-cancer lead compound.
Bioorg Med Chem Lett. 2009 May 15;19(10):2760-2. doi: 10.1016/j.bmcl.2009.03.115. Epub 2009 Mar 28.
本文引用的文献
1
Aryl bis(diazeniumdiolates): potent inducers of S-glutathionylation of cellular proteins and their in vitro antiproliferative activities.
J Med Chem. 2008 Dec 25;51(24):7944-52. doi: 10.1021/jm800831y.
2
Hydrolytic reactivity trends among potential prodrugs of the O2-glycosylated diazeniumdiolate family. Targeting nitric oxide to macrophages for antileishmanial activity.
J Med Chem. 2008 Jul 10;51(13):3961-70. doi: 10.1021/jm8000482. Epub 2008 Jun 6.
3
Prodrugs: design and clinical applications.
Nat Rev Drug Discov. 2008 Mar;7(3):255-70. doi: 10.1038/nrd2468.
4
Synthesis and in vitro anti-leukemic activity of structural analogues of JS-K, an anti-cancer lead compound.
Bioorg Med Chem Lett. 2008 Feb 1;18(3):950-3. doi: 10.1016/j.bmcl.2007.12.044. Epub 2008 Jan 4.
5
Synthesis, nitric oxide release, and anti-leukemic activity of glutathione-activated nitric oxide prodrugs: Structural analogues of PABA/NO, an anti-cancer lead compound.
Bioorg Med Chem. 2008 Mar 1;16(5):2657-64. doi: 10.1016/j.bmc.2007.11.035. Epub 2007 Nov 17.
6
Fluorescent and luminescent probes for measurement of oxidative and nitrosative species in cells and tissues: progress, pitfalls, and prospects.
Free Radic Biol Med. 2007 Oct 1;43(7):995-1022. doi: 10.1016/j.freeradbiomed.2007.06.026. Epub 2007 Jul 10.
7
V-PROLI/NO, a prodrug of the nitric oxide donor, PROLI/NO.
Org Lett. 2007 Aug 16;9(17):3409-12. doi: 10.1021/ol701419a. Epub 2007 Jul 20.
8
Antitumor activity of JS-K [O2-(2,4-dinitrophenyl) 1-[(4-ethoxycarbonyl)piperazin-1-yl]diazen-1-ium-1,2-diolate] and related O2-aryl diazeniumdiolates in vitro and in vivo.
J Med Chem. 2006 Jul 13;49(14):4356-66. doi: 10.1021/jm060022h.
9
Enzymes involved in the bioconversion of ester-based prodrugs.
J Pharm Sci. 2006 Jun;95(6):1177-95. doi: 10.1002/jps.20542.
10
Carboxylesterases--detoxifying enzymes and targets for drug therapy.
Curr Med Chem. 2006;13(9):1045-54. doi: 10.2174/092986706776360969.
Zotero 插件